6 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... therapy for purulent meningitis ... condition #IDSA ... #Meningitis #Antibiotics
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
therapy in bacterial meningitis ... #IDSA #Meningitis ... #Antibiotics #Antimicrobial
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal Meningoencephalitis ... #IDSA #Treatment ... #management #meningitis ... #cryptococcus #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
IDSA Treatment Recommendations ... for Cryptococcal Meningoencephalitis ... for Cryptococcal Meningoencephalitis ... #IDSA #Treatment ... #management #meningitis
CNS Infections - Viral Encephalitis and Bacterial Meningitis - Differential Diagnosis Framework

Viral Encephalitis:
MCC: Enteroviruses (e.g., coxsackievirus
and Bacterial Meningitis ... pressure Lyme Meningoencephalitis ... stain: Previous antibiotics ... • In Bacterial meningitis ... of a non-viral meningitis
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal Meningoencephalitis ... #Cryptococcal #Meningoencephalitis ... #IDSA #Treatment ... #management #meningitis